Project Grant R01NS138288
Award Date
8/13/24
Completion Date
6/30/29
Dollars Obligated
$364K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This Project Grant award, valued at $215,810 and funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the mechanisms by which the herpes simplex virus type 1 (HSV-1) degrades host proteins in neurons to enable viral replication and reactivation from latency. The primary awardee, the University of Virginia, will collaborate with the University of Cambridge to: 1)...
This $471,159 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the mechanisms by which alpha herpesviruses, such as herpes simplex virus-1 (HSV-1), invade the peripheral nervous system. The 5-year research project, awarded to the University of California, Irvine, aims to investigate how the response of peripheral nerve axons to the cytokine...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $236,292 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Tufts University School of Medicine to capture and characterize the structural complexes of the herpes simplex virus (HSV) glycoproteins critical for viral entry. The project aims to use new methods to isolate and analyze the 3D structures of the GD/GH/GL and GH/GL/GB glycoprotein complexes involved in HSV cell entry, which have been...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $658,273 in funding to the University of Massachusetts Medical School to investigate how the Herpes Simplex Virus 1 (HSV-1) regulates the NLRP1 inflammasome pathway and contributes to antiviral defense in human skin. The goals of this 5-year project are to: 1) determine how the HSV-1 ICP0 protein activates...
This $129,454 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to define the contributions of neuronal SUR1-TRPM4 expression to chronic seizure activity. The research will assess the effects of neuron-specific SUR1-TRPM4 overexpression on neuronal hyperexcitability in vitro and seizure susceptibility in vivo. This work could improve...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Massachusetts Medical School provides $4,086,962 to investigate the role of herpesviruses, such as herpes simplex virus 1 (HSV-1), in the pathogenesis of Alzheimer's disease (AD). The award aims to use human in vitro induced pluripotent stem cell (iPSC) models, including cerebral organoids (COrGs), combined with multi-omics data from human samples, to identify transcriptomic...
This federal Project Grant award from the National Institutes of Health (NIH), under the Trans-NIH Research Support (CFDA 93.310) program, provides $1,367,863 to Emory University to conduct biophysical research on herpesvirus capsid assembly and genome packaging. The goal is to develop new methodologies to monitor these essential viral processes in real-time, which could lead to a more complete understanding of herpesviral replication and the development of improved preventative and...
This federal Project Grant award of $651,832 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate how the herpes simplex virus (HSV-1) manipulates the host cell's DNA damage response and proteome to promote viral gene expression and replication. The research team at The Children's Hospital of Philadelphia will use multi-modal proteomics techniques to define how changes to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,486,800.00 to the Albert Einstein College of Medicine to conduct research on the role of TNFRSF14 signaling in promoting antibody-dependent cell-mediated cytotoxicity (ADCC) for herpes simplex virus (HSV) vaccine development. The project aims to identify the signaling pathways and structural determinants that...
This $881,878 federal Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to study the cross-talk between skin-resident T-cells (CD8 T resident memory cells) and keratinocytes, the primary target of herpes simplex virus (HSV) infection, to understand how this interaction influences HSV recurrence. The research will utilize advanced techniques such as single-cell RNA...